In this study, we evaluated the expression and the prognostic significance of T and B lymphocytes and immune checkpoint proteins PD1 and PDL1 in a large well characterised DCIS cohort with long-term follow-up. The gene discussed is PDCD1; the disease is ductal breast carcinoma in situ.